Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial

Table 2 Cost data collected in the My Body My Test-3 study

	Cost Perspective
	Health clinic	Public payers
Training
Developing and delivering call-center training, study personnel time		X
Training call-center agents, materials		X
Attending call-center training, agent personnel time		X
Recruitment
Recruitment materials and advertisements^a		X
Recruitment personnel time^b		X
Screening identification for eligibility
Screening calls, personnel time		X
Self-collection for HPV testing
Non-personnel costs
Self-collection kits, materials, and postage		X
Processing self-collection kits, laboratory materials		X
Reminder letters, as needed, materials and postage		X
Personnel time costs
Mailing self-collection kits		X
Delivering self-collection results and scheduling clinic appointments		X
Mailing reminder letters, as needed, materials		X
Clinic services and procedures
Non-personnel costs
Processing screening tests, laboratory materials	X
Personnel time costs
Scheduling appointment with patient for in-clinic co-testing	X
Processing/completing paperwork for new patient	X
Checking patient in and out	X
Contacting patient who missed appointment	X
Reporting abnormal screening results to patient and making referral for follow up	X
Reporting normal screening results to patient	X
Cost/cost recovery for procedures
Medicaid reimbursement for screening test	X	X

ASHA American Sexual Health Association, HPV Human papillomavirus
^a Costs include postcards, flyers, yard signs, logo design, newspaper ads, radio station advertisements, website, transportation advertisements, and others
^b Costs related to developing and maintaining community partner relationships, direct outreach and recruitment events, distributing recruitment materials, posting advertisements, travel, and administrative procedures

ISSN: 1745-6215